A single-institution experience from the Lapatinib Expanded Access Program – effect of lapatinib and capecitabine combination therapy on CNS metastases in patients with ErbB2+ metastatic breast cancer
B. Kaufman, R. Weitzen, A. Goldfarb, N. Ephrat, I. Kuchuk, T. Golan, I. Wolf, R. EliaVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70735-3
File:
PDF, 62 KB
english, 2008